• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝葡萄糖激酶的激素和代谢物调节。

Hormonal and Metabolite Regulation of Hepatic Glucokinase.

机构信息

Institutes of Cellular Medicine and Ageing and Health, Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH United Kingdom; email:

出版信息

Annu Rev Nutr. 2016 Jul 17;36:389-415. doi: 10.1146/annurev-nutr-071715-051145. Epub 2016 May 4.

DOI:10.1146/annurev-nutr-071715-051145
PMID:27146014
Abstract

Liver glucose metabolism is dependent on glucokinase activity. Glucokinase expression is transcriptionally regulated by hormones and metabolites of glucose, and glucokinase activity is dependent on reversible binding of glucokinase to a specific inhibitor protein, glucokinase regulatory protein (GKRP), and to other binding proteins such as 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase (PFK2/FBP2), which functions as an activator. Glucokinase is inhibited in the postabsorptive state by sequestration in the nucleus bound to GKRP, and it is activated postprandially by portal hyperglycemia and fructose through dissociation from GKRP, translocation to the cytoplasm, and binding to PFK2/FBP2. Glucagon dissociates this interaction, promoting translocation back to the nucleus. In humans, changes in glucokinase expression and activity are associated with poorly controlled type 2 diabetes and with nonalcoholic fatty liver disease, and a common variant of GKRP with altered binding affinity for glucokinase is associated with increased blood and liver lipids and other metabolic traits that implicate a role for GKRP in maintaining intrahepatic metabolite homeostasis.

摘要

肝葡萄糖代谢依赖于葡萄糖激酶的活性。葡萄糖激酶的表达受激素和葡萄糖代谢物的转录调控,其活性依赖于葡萄糖激酶与特定抑制剂蛋白葡萄糖激酶调节蛋白(GKRP)的可逆结合,以及与其他结合蛋白(如 6-磷酸果糖-2-激酶/果糖 2,6-二磷酸酶(PFK2/FBP2))的结合,后者作为激活剂发挥作用。在吸收后状态下,葡萄糖激酶通过与 GKRP 结合而被隔离在核内而被抑制,餐后通过门静脉高血糖和果糖从 GKRP 解离、转位到细胞质以及与 PFK2/FBP2 结合而被激活。胰高血糖素使这种相互作用解离,促进转位回核内。在人类中,葡萄糖激酶表达和活性的变化与 2 型糖尿病控制不佳以及非酒精性脂肪性肝病有关,而 GKRP 的常见变异与葡萄糖激酶结合亲和力改变有关,这与血液和肝脏脂质以及其他代谢特征增加有关,这些特征表明 GKRP 在维持肝内代谢物平衡方面发挥作用。

相似文献

1
Hormonal and Metabolite Regulation of Hepatic Glucokinase.肝葡萄糖激酶的激素和代谢物调节。
Annu Rev Nutr. 2016 Jul 17;36:389-415. doi: 10.1146/annurev-nutr-071715-051145. Epub 2016 May 4.
2
Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein.胰高血糖素通过6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶-2与葡萄糖激酶调节蛋白之间的转移,诱导葡萄糖激酶从肝细胞的细胞质转运至细胞核。
Biochim Biophys Acta. 2014 Jun;1843(6):1123-34. doi: 10.1016/j.bbamcr.2014.02.006. Epub 2014 Feb 22.
3
Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.AMP 活化蛋白激酶对葡萄糖激酶易位的抑制作用与葡萄糖激酶调节蛋白(GKRP)和 6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶的磷酸化有关。
Am J Physiol Regul Integr Comp Physiol. 2008 Mar;294(3):R766-74. doi: 10.1152/ajpregu.00593.2007. Epub 2008 Jan 16.
4
Dual role of phosphofructokinase-2/fructose bisphosphatase-2 in regulating the compartmentation and expression of glucokinase in hepatocytes.磷酸果糖激酶-2/果糖二磷酸酶-2在调节肝细胞中葡萄糖激酶的区室化和表达方面的双重作用。
Diabetes. 2005 Jul;54(7):1949-57. doi: 10.2337/diabetes.54.7.1949.
5
Contributions of glucokinase and phosphofructokinase-2/fructose bisphosphatase-2 to the elevated glycolysis in hepatocytes from Zucker fa/fa rats.葡萄糖激酶和磷酸果糖激酶-2/果糖二磷酸酶-2对Zucker fa/fa大鼠肝细胞糖酵解增强的作用
Am J Physiol Regul Integr Comp Physiol. 2007 Aug;293(2):R618-25. doi: 10.1152/ajpregu.00061.2007. Epub 2007 Jun 6.
6
The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326.GCKR-P446L 基因变异使 P446L 小鼠(GCKR rs1260326 的模型)的血液胆固醇升高和血糖降低。
Mol Metab. 2023 Jun;72:101722. doi: 10.1016/j.molmet.2023.101722. Epub 2023 Apr 7.
7
Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity.葡萄糖激酶调节蛋白的乙酰化通过抑制葡萄糖激酶活性降低葡萄糖代谢。
Sci Rep. 2015 Dec 1;5:17395. doi: 10.1038/srep17395.
8
Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.与 2 型糖尿病风险相关的 GCKR P446L 变异体的细胞特征。
Diabetologia. 2012 Jan;55(1):114-22. doi: 10.1007/s00125-011-2348-5. Epub 2011 Oct 25.
9
Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation.葡萄糖激酶调节蛋白突变的小鼠表现出肝脏葡萄糖激酶减少:代谢调节中的一种隔离机制。
Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14511-6. doi: 10.1073/pnas.96.25.14511.
10
The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.GCKR 基因中的 P446L 变异与空腹血糖和甘油三酯水平相关,其通过增加肝脏中的葡萄糖激酶活性来发挥作用。
Hum Mol Genet. 2009 Nov 1;18(21):4081-8. doi: 10.1093/hmg/ddp357. Epub 2009 Jul 30.

引用本文的文献

1
Therapeutic potential of a choline-zinc-vitamin E nutraceutical complex in ameliorating thioacetamide-induced nonalcoholic fatty liver pathology in zebrafish.胆碱 - 锌 - 维生素E营养复合物改善硫代乙酰胺诱导的斑马鱼非酒精性脂肪肝病理的治疗潜力
PLoS One. 2025 May 20;20(5):e0324164. doi: 10.1371/journal.pone.0324164. eCollection 2025.
2
Role of genetic variants and DNA methylation of lipid metabolism-related genes in metabolic dysfunction-associated steatotic liver disease.脂质代谢相关基因的遗传变异和DNA甲基化在代谢功能障碍相关脂肪性肝病中的作用
Front Physiol. 2025 Mar 17;16:1562848. doi: 10.3389/fphys.2025.1562848. eCollection 2025.
3
Aldose reductase, fructose and fat production in the liver.
肝脏中的醛糖还原酶、果糖与脂肪生成
Biochem J. 2025 Mar 5;482(5):295-307. doi: 10.1042/BCJ20240748.
4
Improved Afternoon Hepatic Glucose Disposal and Storage Requires Morning Engagement of Hepatic Insulin Receptors.改善午后肝脏葡萄糖处置与储存需要早晨肝脏胰岛素受体的参与。
Diabetes. 2025 Mar 1;74(3):270-281. doi: 10.2337/db24-0786.
5
Conserved glucokinase regulation in zebrafish confirms therapeutic utility for pharmacologic modulation in diabetes.斑马鱼中葡萄糖激酶的调节作用较为保守,这一发现为药物调节糖尿病治疗提供了潜在的应用价值。
Commun Biol. 2024 Nov 23;7(1):1557. doi: 10.1038/s42003-024-07264-5.
6
No Difference in Liver Damage Induced by Isocaloric Fructose or Glucose in Mice with a High-Fat Diet.高脂饮食小鼠中,等热量果糖或葡萄糖诱导的肝损伤无差异。
Nutrients. 2024 Oct 21;16(20):3571. doi: 10.3390/nu16203571.
7
Morning Engagement of Hepatic Insulin Receptors Improves Afternoon Hepatic Glucose Disposal and Storage.早晨肝脏胰岛素受体的激活可改善下午肝脏的葡萄糖处置和储存。
bioRxiv. 2024 Sep 27:2024.09.25.614969. doi: 10.1101/2024.09.25.614969.
8
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care.2型糖尿病的现代挑战:新药物与多因素护理的平衡
Biomedicines. 2024 Sep 7;12(9):2039. doi: 10.3390/biomedicines12092039.
9
Liver-specific actions of GH and IGF1 that protect against MASLD.生长激素(GH)和胰岛素样生长因子1(IGF1)的肝脏特异性作用可预防代谢相关脂肪性肝病(MASLD)。
Nat Rev Endocrinol. 2025 Feb;21(2):105-117. doi: 10.1038/s41574-024-01037-0. Epub 2024 Sep 25.
10
Glucokinase (GCK) in diabetes: from molecular mechanisms to disease pathogenesis.葡萄糖激酶(GCK)在糖尿病中的作用:从分子机制到疾病发病机制。
Cell Mol Biol Lett. 2024 Sep 8;29(1):120. doi: 10.1186/s11658-024-00640-3.